Wellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine & Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester M13 9PT, UK.
Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Cheshire SK10 4TG, UK.
Matrix Biol. 2022 Jun;110:16-39. doi: 10.1016/j.matbio.2022.03.010. Epub 2022 Apr 9.
Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis due to its aggressive progression, late detection and lack of druggable driver mutations, which often combine to result in unsuitability for surgical intervention. Together with activating mutations of the small GTPase KRas, which are found in over 90% of PDAC tumours, a contributory factor for PDAC tumour progression is formation of a rigid extracellular matrix (ECM) and associated desmoplasia. This response leads to aberrant integrin signalling, and accelerated proliferation and invasion. To identify the integrin adhesion systems that operate in PDAC, we analysed a range of pancreatic ductal epithelial cell models using 2D, 3D and organoid culture systems. Proteomic analysis of isolated integrin receptor complexes from human pancreatic ductal epithelial (HPDE) cells predominantly identified integrin α6β4 and hemidesmosome components, rather than classical focal adhesion components. Electron microscopy, together with immunofluorescence, confirmed the formation of hemidesmosomes by HPDE cells, both in 2D and 3D culture systems. Similar results were obtained for the human PDAC cell line, SUIT-2. Analysis of HPDE cell secreted proteins and cell-derived matrices (CDM) demonstrated that HPDE cells secrete a range of laminin subunits and form a hemidesmosome-specific, laminin 332-enriched ECM. Expression of mutant KRas (G12V) did not affect hemidesmosome composition or formation by HPDE cells. Cell-ECM contacts formed by mouse and human PDAC organoids were also assessed by electron microscopy. Organoids generated from both the PDAC KPC mouse model and human patient-derived PDAC tissue displayed features of acinar-ductal cell polarity, and hemidesmosomes were visible proximal to prominent basement membranes. Furthermore, electron microscopy identified hemidesmosomes in normal human pancreas. Depletion of integrin β4 reduced cell proliferation in both SUIT-2 and HPDE cells, reduced the number of SUIT-2 cells in S-phase, and induced G1 cell cycle arrest, suggesting a requirement for α6β4-mediated adhesion for cell cycle progression and growth. Taken together, these data suggest that laminin-binding adhesion mechanisms in general, and hemidesmosome-mediated adhesion in particular, may be under-appreciated in the context of PDAC. Proteomic data are available via ProteomeXchange with the identifiers PXD027803, PXD027823 and PXD027827.
胰腺导管腺癌(PDAC)由于其侵袭性进展、晚期检测和缺乏可用药的驱动突变,预后不佳,这些因素通常导致其不适合手术干预。与超过 90%的 PDAC 肿瘤中发现的小 GTPase KRas 的激活突变一起,PDAC 肿瘤进展的一个促成因素是刚性细胞外基质(ECM)的形成和相关的纤维组织增生。这种反应导致整合素信号异常,加速增殖和侵袭。为了确定在 PDAC 中起作用的整合素粘附系统,我们使用二维、三维和类器官培养系统分析了一系列胰腺导管上皮细胞模型。对人胰腺导管上皮(HPDE)细胞中分离的整合素受体复合物的蛋白质组学分析主要鉴定了整合素 α6β4 和半桥粒成分,而不是经典的粘着斑成分。电子显微镜和免疫荧光共定位证实了 HPDE 细胞在二维和三维培养系统中形成半桥粒。人 PDAC 细胞系 SUIT-2 也得到了类似的结果。对 HPDE 细胞分泌蛋白和细胞衍生基质(CDM)的分析表明,HPDE 细胞分泌多种层粘连蛋白亚基,并形成半桥粒特异性的富含层粘连蛋白 332 的 ECM。HPDE 细胞中突变型 KRas(G12V)的表达不影响半桥粒的组成或形成。电子显微镜还评估了来自小鼠和人 PDAC 类器官的细胞-ECM 接触。来自 PDAC KPC 小鼠模型和人源性 PDAC 组织的类器官均显示出腺泡-导管细胞极性的特征,并且在突出的基底膜附近可以看到半桥粒。此外,电子显微镜在正常的人胰腺中也鉴定出了半桥粒。整合素β4 的耗竭减少了 SUIT-2 和 HPDE 细胞的增殖,减少了 SUIT-2 细胞在 S 期的数量,并诱导了 G1 细胞周期阻滞,表明 α6β4 介导的粘附对于细胞周期进程和生长是必需的。总之,这些数据表明,在 PDAC 中,层粘连蛋白结合的粘附机制一般,特别是半桥粒介导的粘附可能被低估了。蛋白质组学数据可通过 ProteomeXchange 获得,标识符为 PXD027803、PXD027823 和 PXD027827。